Biotechnology cancer Clinical Trials Radiopharmaceuticals FDA Greenlights Orphan Drug Status for Radioimmuneconjugate for Treating Refractory and Relapsed Acute Myeloid Leukemia in Elderly Patients By Staff Reports 4 years ago The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Iomab-B, a
Biotechnology Cell Therapy Clinical Trials Diabetes Sketches Of Progress By Staff Reports 4 years ago By Richard (Rick) Mills, Editor of Aheadoftheherd.com Disruptive innovations have the potential to truly reshape
Biomarkers Clinical Trials Diagnostic Testing New Funding Sought for Development of Diagnostic Test and Therapeutic Drug for Traumatic Brain Injury (TBI) By Staff Reports 4 years ago Medicortex Finland Oy, a start-up biotechnology company focused on the diagnosis and treatment of neurodegenerative
Biotechnology cancer Clinical Trials Cancer Immunotherapies take Center Stage By Staff Reports 5 years ago The newly created task force on cancer, in what Vice President Joe Biden has called
Biotechnology cancer Clinical Trials Many Targeted Cancer Therapies Suppress T Cell Immune Responses By Staff Reports 5 years ago In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery
cancer Clinical Trials UGA Researchers Find Potential Treatment for Prostate Cancer By Staff Reports 5 years ago Researchers at the University of Georgia have created a new therapeutic for prostate cancer that
Arthritis Biotechnology Clinical Trials Pharmaceuticals Prescriptions New Study Shows Common NSAIDs can cause more Harm than Good By Staff Reports 5 years ago Many patients around the world, are prescribed non-steroidal anti-inflammatory drugs (called NSAIDs) for the treatment